SOLV

NYSE

Solventum Corp

Health Care, Health Care Technology

$82.98

close 7 Aug 2026

+15.47%

52-week change

$14.12B

market cap

$62.38

$90.00

52-week range

Valuation

Market cap$14.12B

P/E (TTM / 5y avg)10.13x16.77x

Forward P/E (FY2026 / FY2027)11.54x11.54x

PEG (TTM / fwd)2.25314.32

P/S (TTM)1.70x

P/B2.94x

EV/EBITDA (TTM)7.31x

FCF yield (TTM)-0.84%

Cash flow & dividend

FCF (TTM)-$118.00M

FCF per share (TTM)-$0.6937

FCF margin (TTM)-1.42%

Dividend yield (indicated / 5y avg)——

Annualized dividend—

Payout ratio (EPS / FCF)——

Growth & quality

Revenue YoY, latest Q+2.22%

Diluted EPS YoY, latest Q+3.92%

Operating margin (TTM)24.99%

Net margin (TTM)17.26%

ROE (latest FY)30.82%

Net debt / EBITDA (TTM)1.82

Interest coverage (TTM)—

Price

+19.31%+7.77%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

Diluted EPS

FCF per share

Operating cash flow

Free cash flow

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

Net debt / EBITDA

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date4 Nov 2026

EPS estimate$1.45

Revenue estimate$2.00B

Last reported

Date—

EPS——

Revenue——